Stocktoria

Cocrystal Pharma, Inc. COCP

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-03-12 · LEI

Cocrystal Pharma, Inc. statistics & valuation

Market cap$14.1M
P / B2.2×
Return on equity-139.5%
Return on capital-120.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-737.40% -476.00% 2016201720182019202020212022202320242025
Return on equity (%)
-73.20% -0.60% -73.30% -187.40% -18.40% -18.30% -98.10% -68.20% -183.80% -139.50% 2016201720182019202020212022202320242025
Shares outstanding
23.8M 24.3M 29.9M 35.1M 70.4M 8.1M 8.1M 10.2M 10.2M 13.8M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-60.00% -0.50% -71.50% -168.80% -17.80% -17.90% -95.10% -57.50% -130.10% -90.90% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-26.00% -500.00% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$3.30 -$0.03 -$4.77 -$1.87 -$1.72 -$0.78 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin—————-476.0%-737.4%———
Net margin—————-479.0%-733.8%———
FCF margin—————-500.0%-26.0%———
Return on assets-90.9%-130.1%-57.5%-95.1%-17.9%-17.8%-168.8%-71.5%-0.5%-60.0%
Return on equity-139.5%-183.8%-68.2%-98.1%-18.3%-18.4%-187.4%-73.3%-0.6%-73.2%
Current ratio3.684.778.9233.0438.4025.053.621.891.512.68

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.